Abstract

Bovine colostrum (ВС) has a high biological value, which allows it to be used for the development of new functional products. The aim of the study was to assess the possibility of using BC for the prevention and treatment of infectious and non-infectious diseases. Material and methods. The search for scientific information on the study of the component composition, immunobiological properties and the use of BC in clinical practice was carried out using the databases of the RSCI, CyberLeninka, ScienceDirect, PubMed. Results. The macro- and micronutrient composition of BC is presented, its changes over time from the moment of calving are described. A comparative analysis of the content of various components in milk and colostrum is presented. A detailed list of antimicrobial factors that increase nonspecific resistance and provide immunocorrective, antimicrobial and anti-inflammatory effects is submitted. The possibility of using BC in clinical practice as a part of complex therapy in the treatment of various infectious diseases, including severe acute respiratory syndrome caused by the new coronavirus infe ction SARS-CoV-2, as well as in cardiovascular diseases, allergies, autoimmune and oncological diseases, has been demonstrated. Conclusion. According to the literature, BC has a high safety profile and is applicable to all age groups of the population. Given the wide range of biological activity of BC components, a promising area of scientific research is the development of the products for therapeutic and prophylactic purposes, including dietary supplements, based on its ingredients, which have the desired properties for correcting the immune status, preventing non-communicable and infectious diseases, as well as for prevention of occupational diseases among persons working in harmful working conditions.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call